Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer s Q2 Income, Revenues Up

This story has been corrected. A previous version erroneously stated that PerkinElmer had $165.5 million cash and cash equivalents at the end of the second quarter last year.


NEW YORK, July 28 (GenomeWeb News) - PerkinElmer Tuesday reported a second-quarter rise in income and revenues, as well as a revenue increase for its life and analytical sciences business.


The company reported income of $20.8 million or $.16 per share compared to $8.4 million or $.07 per share in the second quarter of 2003, while revenues for the quarter totaled $412.6 million, compared to $376.3 million for the year-ago quarter.


Revenues in the life and analytical sciences segment were $257.9 million, versus $246 million for the same period last year.


R&D expenses for the second quarter came to $22.3 million, up slightly from the $21.9 million reported in the same period last year.


As of June 27, the company had $196.7 million in cash and cash equivalents, compared to $165.5 million at the end of the first quarter.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.